Your Cannabis Data Collection Partner
Take your regulated product to market faster with our streamlined data collection solutions.
Our clients trust our protocols for FDA pre-market product approvals, backed by over 50 years as an industry-leading research provider. Our expert team works with you to customize comprehensive cannabis data collection solutions that deliver reliable, actionable data.
Achieve Regulatory
Body Approval
Bring Your Product
To Market Faster
Substantiate
Unique Claims
Supporting a Broad Range of Testing
Label Comprehension
Actual Use Tests (AUT)
Claims Substantiation
Product Testing
Behavioral Research
Observational Studies
User Experience
Packaging Design
Regulated Data Collection Expertise
Extensive experience with
successful PMA submissions
Our expertise in recruiting subjects provides unparalleled access to your intended audience with secure data as mandated by the FDA.
Rigorous project execution
Our team works closely with you to develop or follow clinical study protocols, manage interactions with the IRB, and deliver quality results nationwide efficiently to support your FDA reporting needs.
Connect with Your Consumers
Our deeply profiled proprietary panel of opted-in consumers and patients powers our ability to connect you with your target audience for your important cannabis studies.
Consumable Users
Medicinal Users
Recreational Users
Integrated Proprietary Data Collection Sites
Our world-class Schlesinger Group insights, testing, and simulation sites are located in key markets across the US and Europe. We coordinate all aspects of clinical research in each location with consistently high quality.
At Schlesinger Clinical Research, our expertise in participant recruiting and clinical project execution provides unparalleled access to your target audiences for data you can trust. Certified teams and 30 proprietary sites across key markets in the US, together with one Clinical Project leader, provides study consistency and quality to your timeline.
